• An Improved Solid-phase Extraction Product for the  Banned Antibiotic Chloramphenicol


An Improved Solid-phase Extraction Product for the Banned Antibiotic Chloramphenicol

Jul 21 2006

MIP Technologies AB announced today the launch of MIP4SPE Chloramphenicol, a specialist product for the Analytical Separations market. This product is a solid-phase extraction (SPE) sorbent specific for Chloramphenicol, a broad spectrum antibiotic frequently employed in animal and fish production in certain parts of the world because of its excellent antibacterial and pharmacokinetic properties. Due to the suspicion that Chloramphenicol is carcinogenic and that it can cause aplastic anaemia in humans it was totally banned in the EU in 1994.

Today, a zero tolerance level for food exists since maximum tolerance levels cannot be established for compounds with this level of toxicity. By using the MIP[4]SPE phase, residues of Chloramphenicol can be extracted efficiently and rapidly, improving considerably on existing extraction methods. Furthermore, detection limits well below the minimum required performance limit (MRPL) for Chloramphenicol are achieved, enhancing the reliability of the detection and ensuring improved food safety and quality.

One of the first companies to test MIP[4]SPE is the Nestlé Research Centre in Lausanne, Switzerland. "We are excited to test this new product for selective extraction of Chloramphenicol from food matrices, and we hope that using a MIP in combination with MS detection will lead to accelerate the turn-around-time for analysis and to lower detection limits compared with other methods", said Dr. Philippe Guy from the Nestlé Research Centre.

Digital Edition

MAC Guide 2023/24

December 2023

Buyers Guide - Major producers of analytical equipment who wish to introduce and sell their products to buyers in science and industry - Over 1,000 products and services that these companys man...

View all digital editions


Instrumentation Live

Jan 17 2024 Birmingham, UK

Smart Factory Expo 2023

Jan 24 2024 Tokyo, Japan

Arab Health

Jan 29 2024 Dubai, UAE

Nano Tech 2024

Jan 31 2024 Tokyo, Japan

SLAS 2024

Feb 03 2024 Boston, MA, USA

View all events